In-Clinic Activity Promotion for Children With Congenital Heart Disease: Randomized Clinical Trial

Patricia E Longmuir1, Jane Lougheed2, Andrew S Mackie3

  • 1Children's Hospital of Eastern Ontario Research Institute and University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.

Insights

A new in-clinic counseling intervention improved physical activity in children with congenital heart disease. This approach is feasible for clinicians and helps children meet daily activity goals.

Area of Science:

  • Pediatrics
  • Cardiology
  • Exercise Science

Background:

  • Children with congenital heart disease (CHD) require effective strategies to promote physical activity.
  • Current clinical practice often falls short of recommended physical activity promotion for pediatric CHD patients.
  • There is a need for feasible interventions that clinicians can integrate into routine care.

Purpose of the Study:

  • To evaluate the feasibility and efficacy of a brief, in-clinic physical activity counseling intervention for children with moderate to severe CHD.
  • To assess the impact of the intervention on daily physical activity levels over a 6-month period.
  • To determine the healthcare system impacts, including clinician compliance and patient perceptions.

Main Methods:

  • A pragmatic, single-blind, multicenter randomized clinical trial involving 155 children (aged 5-17 years) with CHD.
  • Intervention group received standardized counseling and kinesiologist support during clinic visits.
  • Primary outcome: daily steps measured by pedometer over 6 months; secondary outcomes: counseling rates, visit length, perceptions, referrals.

Main Results:

  • Intervention participants maintained daily activity above 12,000 steps, while control group activity declined significantly by month 5.
  • Highly active participants at baseline maintained their activity levels in both groups.
  • The intervention was feasible, with 97% of participants counseled and no increase in clinic visit duration.

Conclusions:

  • A brief, standardized in-clinic counseling intervention with kinesiology support effectively increased and maintained physical activity in children with CHD.
  • The intervention is feasible for clinicians, enabling compliance with recommended activity promotion guidelines.
  • This approach supports children with CHD in achieving recommended daily physical activity levels.
Abstract

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
591
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
219
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
466